Portage Biotech Inc. (PRTG) Financials

PRTG Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2023 50.6 million 19.3 million
Sept. 30, 2023 92.4 million 25.4 million
June 30, 2023 99.1 million 23.7 million
March 31, 2023 99.1 million 23.7 million

PRTG Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -3.3 million 736000
Sept. 30, 2023 -4.3 million 742
June 30, 2023 -4.7 million 662000
March 31, 2023 -4.7 million 662000

PRTG Net Income

No data available :(

PRTG Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 5.3 million - 275000
Sept. 30, 2023 3.4 million - 286000
June 30, 2023 10.5 million - 296000
March 31, 2023 10.5 million - -

PRTG Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 20.9 million
Sept. 30, 2023 17.8 million
June 30, 2023 17.3 million
March 31, 2023 17.6 million

PRTG Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 - 2.8 million 1.3 million -
Sept. 30, 2023 - 4.2 million 1.7 million -
June 30, 2023 43 2.2 million 1.8 million -
March 31, 2023 - 2.2 million 1.8 million -

PRTG Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 - 15000
Sept. 30, 2023 - 14999
June 30, 2023 - 11000
March 31, 2023 - -

PRTG

Price: $6.81

52 week price:
2.81
23.01

Earnings Per Share: -5.72 USD

P/E Ratio: -1.19

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: British Virgin Islands

Volume: 55400

Market Capitalization: 15.5 million

Links: